A/Prof John Ding was the founding member and Chair of the Young Gastroenterology Society of Australia and lead gastroenterologist for the National Bowel Cancer Program at St Vincent’s Hospital, Melbourne.

Having completed his PhD at one of the world’s leading centres in colorectal cancer and IBD care, St Mark’s Hospital, London, he now divides his time between private practice and a senior medical specialist appointment at St Vincent’s Hospital where he is a part of the gastroenterology and inflammatory bowel disease units. He teaches gastroenterologists and trainees and is an invited speaker nationally and internationally in the field of gastroenterology.

He has held numerous grants awarded by government through the National Health and Medical Research Council (NHMRC) and European Crohn’s and Colitis Organisation (ECCO), with an appointment onto its European committee. His PhD research investigating the personalisation of medical therapy for patients with IBD using microbiome and metabolic profiling has led to numerous publications and been cited internationally.

A/Prof John Ding engages and leads on research projects in numerous areas through international consortium GETAID, Imperial College, St Vincent’s Hospital and the University of Melbourne. He additionally holds the position of head of the IBD Clinical Trials Unit at St Vincent’s Hospital and lead for the National Bowel Cancer Program.

He supervises PhD students and post-doctoral researchers who actively investigate causes for bowel and gastrointestinal diseases. His current research also focusses on early-onset bowel cancer and how to improve access to screening. He has co-founded and is the director of a medical healthcare company, Medcompanion.com.au that is aimed at improving patient care with bowel preparation instructions for colonoscopy.